lifestyle.briefmobile.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Aperture Therapeutics
Aperture Therapeutics Announces First-In-Class MMP9 Antisense Oligonucleotide Program for ALS
January 6, 2026
Aperture Therapeutics Announces Development Candidate Targeting CD33 to Restore Microglial Homeostasis in FTD and ALS
November 21, 2025